As a bioscience futurist, Gary joins the cc-TDI Executive Board of Directors to leverage his career experience planning biomedical capital projects, shaping a bio-economic development agency
Congratulations to summer intern, Cora, for her publication of “Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma“. Cora and our collaborators David Gutmann
As a bioscience futurist, Gary joins the cc-TDI Executive Board of Directors to leverage his career experience planning biomedical capital projects, shaping a bio-economic development agency
Congratulations to summer intern, Cora, for her publication of “Challenges in Drug Discovery for Neurofibromatosis Type 1-Associated Low-Grade Glioma“. Cora and our collaborators David Gutmann
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2024 – Children’s Cancer Therapy Development Institute